The CloudTMS system manufactured by Neurosoft Ltd is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.
Using the CloudTMS system for any indication(s) not currently cleared by the FDA is considered for investigational use only. By clicking agree or by using any techniques outlined in the video and text within, you indicate your agreement with these terms and conditions.I agree
CloudNeuro's primary aim is to make the practice of neurology and psychiatry more accessible through disruptive technologies.
Contact us to find out more about our CloudEMG and CloudTMS products.
Originally established in 1996 as an educational website in the field of Neurology by Dr Joe Jabre MD a board certified neurologist, CloudNeuro has grown to 20 employees with offices in Boston, New York, and Los Angeles.
Our FDA cleared products include CloudTMS, a repetitive TMS device for the treatment of drug resistant depression. CloudEMG, a diagnostic device for pain and neuropathy, and CloudEEG, a fully fledged 32 lead EEG device.
All of our devices are integrated into our world class cloud-based platform enabling the modern practionner to access their data on the go and analyze trends using powerful expert systems, practice dashboards and reporting.